Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 37 | 2023 | 67 | 12.490 |
Why?
|
| Obesity, Morbid | 36 | 2023 | 98 | 10.680 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 172 | 5.290 |
Why?
|
| Weight Loss | 20 | 2022 | 120 | 4.390 |
Why?
|
| Bariatric Surgery | 14 | 2023 | 51 | 4.290 |
Why?
|
| Laparoscopy | 29 | 2022 | 160 | 3.900 |
Why?
|
| Postoperative Complications | 13 | 2023 | 866 | 2.040 |
Why?
|
| Insulin Resistance | 6 | 2018 | 45 | 1.960 |
Why?
|
| Obesity | 8 | 2022 | 278 | 1.930 |
Why?
|
| Gastroesophageal Reflux | 12 | 2012 | 25 | 1.630 |
Why?
|
| Middle Aged | 52 | 2022 | 8585 | 1.520 |
Why?
|
| Gastrectomy | 7 | 2023 | 29 | 1.440 |
Why?
|
| Adipose Tissue | 4 | 2018 | 62 | 1.350 |
Why?
|
| Female | 56 | 2022 | 14499 | 1.300 |
Why?
|
| Adult | 41 | 2022 | 7437 | 1.300 |
Why?
|
| Fundoplication | 10 | 2012 | 18 | 1.290 |
Why?
|
| Humans | 79 | 2023 | 26227 | 1.290 |
Why?
|
| Male | 52 | 2022 | 14107 | 1.240 |
Why?
|
| Prospective Studies | 21 | 2022 | 1669 | 1.180 |
Why?
|
| Body Mass Index | 9 | 2020 | 428 | 1.150 |
Why?
|
| Gastroplasty | 6 | 2019 | 23 | 1.120 |
Why?
|
| Insulin | 4 | 2016 | 76 | 1.110 |
Why?
|
| Esophageal Achalasia | 7 | 2015 | 17 | 1.020 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 140 | 0.920 |
Why?
|
| Bibliometrics | 2 | 2021 | 30 | 0.880 |
Why?
|
| General Surgery | 2 | 2021 | 47 | 0.860 |
Why?
|
| Quality of Life | 7 | 2016 | 620 | 0.850 |
Why?
|
| Caloric Restriction | 2 | 2014 | 13 | 0.850 |
Why?
|
| Treatment Outcome | 22 | 2022 | 3381 | 0.850 |
Why?
|
| Biomarkers | 3 | 2020 | 556 | 0.810 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2015 | 21 | 0.810 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 1735 | 0.800 |
Why?
|
| Adiponectin | 2 | 2012 | 7 | 0.800 |
Why?
|
| Omentum | 2 | 2012 | 8 | 0.790 |
Why?
|
| Bone Density | 2 | 2020 | 142 | 0.780 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 33 | 0.730 |
Why?
|
| Case-Control Studies | 9 | 2019 | 564 | 0.730 |
Why?
|
| Esophagus | 3 | 2012 | 62 | 0.720 |
Why?
|
| Weight Gain | 2 | 2021 | 61 | 0.710 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 58 | 0.700 |
Why?
|
| Mental Disorders | 1 | 2022 | 126 | 0.700 |
Why?
|
| Osteoclasts | 1 | 2020 | 19 | 0.690 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 35 | 0.680 |
Why?
|
| Protein Precursors | 1 | 2019 | 18 | 0.670 |
Why?
|
| Fractures, Bone | 1 | 2020 | 76 | 0.650 |
Why?
|
| Neoplasms | 1 | 2022 | 221 | 0.640 |
Why?
|
| Retrospective Studies | 15 | 2023 | 3365 | 0.620 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 6 | 0.610 |
Why?
|
| Postprandial Period | 3 | 2016 | 4 | 0.600 |
Why?
|
| Aged | 22 | 2022 | 8749 | 0.550 |
Why?
|
| Vascular Diseases | 1 | 2016 | 43 | 0.520 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2016 | 10 | 0.520 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 31 | 0.510 |
Why?
|
| Adipocytes | 2 | 2012 | 12 | 0.510 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 333 | 0.490 |
Why?
|
| Peptide YY | 2 | 2011 | 2 | 0.490 |
Why?
|
| Leptin | 2 | 2011 | 19 | 0.490 |
Why?
|
| Anastomosis, Roux-en-Y | 4 | 2007 | 7 | 0.460 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 4 | 0.450 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 55 | 0.430 |
Why?
|
| Time Factors | 6 | 2016 | 1382 | 0.420 |
Why?
|
| Gastric Acid | 1 | 2012 | 8 | 0.420 |
Why?
|
| Postoperative Period | 5 | 2020 | 312 | 0.410 |
Why?
|
| Nomograms | 1 | 2012 | 5 | 0.410 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 7 | 0.400 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.390 |
Why?
|
| Appetite | 1 | 2011 | 4 | 0.390 |
Why?
|
| Blood Glucose | 4 | 2014 | 99 | 0.390 |
Why?
|
| Cohort Studies | 5 | 2022 | 1841 | 0.390 |
Why?
|
| Cell Differentiation | 1 | 2012 | 124 | 0.390 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 39 | 0.380 |
Why?
|
| Reoperation | 5 | 2021 | 883 | 0.380 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 80 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 149 | 0.360 |
Why?
|
| Catheter Ablation | 4 | 2004 | 74 | 0.330 |
Why?
|
| Bone and Bones | 2 | 2019 | 110 | 0.300 |
Why?
|
| Adolescent | 7 | 2020 | 2078 | 0.300 |
Why?
|
| Risk Factors | 8 | 2021 | 2267 | 0.300 |
Why?
|
| Body Composition | 2 | 2021 | 62 | 0.300 |
Why?
|
| United States | 6 | 2022 | 1991 | 0.300 |
Why?
|
| Deglutition Disorders | 2 | 2007 | 35 | 0.290 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2007 | 3 | 0.280 |
Why?
|
| Coronary Disease | 1 | 2007 | 51 | 0.280 |
Why?
|
| Young Adult | 6 | 2020 | 1886 | 0.280 |
Why?
|
| Incidence | 2 | 2022 | 717 | 0.270 |
Why?
|
| Esophagectomy | 1 | 2006 | 21 | 0.260 |
Why?
|
| Laparotomy | 2 | 2021 | 19 | 0.260 |
Why?
|
| Esophagoscopy | 5 | 2005 | 9 | 0.250 |
Why?
|
| Cholecystitis | 3 | 2023 | 10 | 0.250 |
Why?
|
| Hypoglycemia | 2 | 2016 | 12 | 0.250 |
Why?
|
| Esophageal Neoplasms | 2 | 2005 | 44 | 0.240 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 309 | 0.240 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2012 | 9 | 0.230 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.230 |
Why?
|
| Prognosis | 5 | 2020 | 758 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 92 | 0.220 |
Why?
|
| Absorptiometry, Photon | 2 | 2014 | 79 | 0.220 |
Why?
|
| Preoperative Period | 3 | 2019 | 78 | 0.220 |
Why?
|
| Transcription Factors | 1 | 2004 | 159 | 0.220 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 123 | 0.220 |
Why?
|
| Apoptosis | 1 | 2004 | 193 | 0.220 |
Why?
|
| Gallstones | 1 | 2023 | 8 | 0.220 |
Why?
|
| Patient Readmission | 2 | 2021 | 129 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2021 | 32 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 254 | 0.210 |
Why?
|
| Fibronectins | 1 | 2022 | 21 | 0.200 |
Why?
|
| Remission Induction | 2 | 2016 | 89 | 0.200 |
Why?
|
| Metabolome | 1 | 2021 | 16 | 0.190 |
Why?
|
| Preoperative Care | 2 | 2016 | 122 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 99 | 0.190 |
Why?
|
| Comorbidity | 2 | 2021 | 475 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 6 | 0.190 |
Why?
|
| Cells, Cultured | 2 | 2012 | 473 | 0.180 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.180 |
Why?
|
| Metronidazole | 1 | 2020 | 5 | 0.180 |
Why?
|
| Levofloxacin | 1 | 2020 | 3 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2021 | 136 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 215 | 0.180 |
Why?
|
| Linear Models | 2 | 2014 | 239 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 31 | 0.170 |
Why?
|
| Medicare | 1 | 2021 | 114 | 0.170 |
Why?
|
| Morbidity | 1 | 2020 | 55 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2014 | 629 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 852 | 0.170 |
Why?
|
| Analysis of Variance | 2 | 2019 | 252 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2020 | 72 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 294 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 312 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 31 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.150 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.150 |
Why?
|
| Length of Stay | 2 | 2017 | 304 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 156 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 184 | 0.140 |
Why?
|
| Gene Expression | 1 | 2017 | 180 | 0.140 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 311 | 0.140 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 12 | 0.130 |
Why?
|
| Recurrence | 1 | 2016 | 314 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2007 | 1075 | 0.120 |
Why?
|
| Gastroscopy | 2 | 2004 | 7 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mental Health | 1 | 2016 | 105 | 0.120 |
Why?
|
| Amino Acids | 1 | 2014 | 17 | 0.120 |
Why?
|
| Lipids | 1 | 2014 | 28 | 0.120 |
Why?
|
| Biliopancreatic Diversion | 1 | 2013 | 1 | 0.110 |
Why?
|
| Duodenum | 1 | 2013 | 6 | 0.110 |
Why?
|
| Carbon | 1 | 2013 | 8 | 0.110 |
Why?
|
| Choline | 1 | 2013 | 5 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2014 | 198 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2013 | 21 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 18 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 561 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 33 | 0.100 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2011 | 1 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ghrelin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 184 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 91 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 10 | 0.100 |
Why?
|
| Fasting | 1 | 2011 | 13 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 272 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2012 | 132 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 450 | 0.100 |
Why?
|
| Food | 1 | 2011 | 29 | 0.100 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 134 | 0.090 |
Why?
|
| Suture Techniques | 3 | 2007 | 150 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2012 | 264 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2015 | 31 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 234 | 0.090 |
Why?
|
| Aging | 2 | 2018 | 1536 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2009 | 26 | 0.090 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 12 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 36 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4670 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 17 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 117 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 22 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 38 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 35 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2006 | 21 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2007 | 60 | 0.070 |
Why?
|
| Tennessee | 1 | 2006 | 9 | 0.070 |
Why?
|
| Operative Time | 2 | 2017 | 84 | 0.070 |
Why?
|
| Markov Chains | 1 | 2006 | 30 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2006 | 20 | 0.070 |
Why?
|
| Gastroenterostomy | 1 | 2005 | 1 | 0.070 |
Why?
|
| Body Weight | 1 | 2006 | 121 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 27 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 186 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 48 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 34 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 75 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 126 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 176 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 72 | 0.060 |
Why?
|
| Equipment Design | 4 | 2006 | 144 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 290 | 0.060 |
Why?
|
| Diet | 1 | 2006 | 170 | 0.060 |
Why?
|
| Choledocholithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cholecystolithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.060 |
Why?
|
| Logistic Models | 1 | 2005 | 365 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 34 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 79 | 0.060 |
Why?
|
| Laryngitis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 5 | 0.060 |
Why?
|
| Laryngostenosis | 1 | 2004 | 5 | 0.060 |
Why?
|
| Animals | 2 | 2018 | 3388 | 0.060 |
Why?
|
| Calcium | 1 | 2007 | 368 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 231 | 0.060 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 5 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 314 | 0.060 |
Why?
|
| Bile | 2 | 1993 | 4 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 8 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 28 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2022 | 28 | 0.050 |
Why?
|
| Standard of Care | 1 | 2021 | 10 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 15 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2021 | 18 | 0.050 |
Why?
|
| Postmenopause | 1 | 2019 | 49 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 81 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 332 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 33 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 13 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 338 | 0.040 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 1997 | 1 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2017 | 133 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 305 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 49 | 0.030 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 2 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 1996 | 2 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 93 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 147 | 0.030 |
Why?
|
| Jejunum | 2 | 2006 | 11 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 448 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 10 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 222 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 128 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 749 | 0.030 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 2 | 0.030 |
Why?
|
| Appendectomy | 1 | 2015 | 15 | 0.030 |
Why?
|
| Manometry | 2 | 2005 | 15 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 29 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 49 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 3 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 200 | 0.030 |
Why?
|
| Learning Curve | 1 | 2012 | 15 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 16 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 123 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 335 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 25 | 0.020 |
Why?
|
| Computers | 1 | 1990 | 21 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 194 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 483 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 85 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2006 | 2 | 0.020 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mesocolon | 1 | 2006 | 1 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 5 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2006 | 4 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 3 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 91 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 8 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 7 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2006 | 10 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 105 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2006 | 10 | 0.020 |
Why?
|
| Hernia | 1 | 2006 | 9 | 0.020 |
Why?
|
| Marital Status | 1 | 2006 | 11 | 0.020 |
Why?
|
| Needles | 1 | 2006 | 20 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2006 | 3 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 70 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2005 | 20 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 322 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 35 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 63 | 0.020 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 4 | 0.020 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 3 | 0.020 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 8 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 11 | 0.020 |
Why?
|
| Choledochostomy | 1 | 2004 | 1 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 2004 | 2 | 0.020 |
Why?
|
| Cholangiography | 1 | 2004 | 11 | 0.020 |
Why?
|
| Gastroscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophagoscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2004 | 2 | 0.010 |
Why?
|
| Polyvinyls | 1 | 2004 | 3 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 11 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 122 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 75 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 399 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 7 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 676 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 10 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 459 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 935 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 190 | 0.010 |
Why?
|
| Colostomy | 1 | 1996 | 2 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 26 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 46 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 128 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 614 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 7 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1992 | 6 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1992 | 9 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1990 | 8 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 18 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 419 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 347 | 0.010 |
Why?
|